Live feed07:00:00·800dPRReleasevia QuantisnowMETIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung CancerByQuantisnow·Wall Street's wire, on your screen.NVCR· NovoCure LimitedHealth Care
